SEARCH

SEARCH BY CITATION

References

  • Basu A., Krady J. K., Enterline J. R. and Levison S. W. (2002) Transforming growth factor beta1 prevents IL-1beta-induced microglial activation, whereas TNFalpha- and IL-6-stimulated activation are not antagonized. Glia 40, 109120.
  • Basu A., Krady J. K. and Levison S. W. (2004) Interleukin-1: a master regulator of neuroinflammation. J. Neurosci. Res. 78, 151156.
  • Brondello J. M., Pouyssegur J. and McKenzie F. R. (1999) Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286, 25142517.
  • Caretti G., Salsi V., Vecchi C., Imbriano C. and Mantovani R. (2003) Dynamic recruitment of NF-Y and histone acetyltransferases on cell-cycle promoters. J. Biol. Chem. 278, 3043530440.
  • Chen B., Tardell C., Higgins B., Packman K., Boylan J. F. and Niu H. (2012) BRAFV600E negatively regulates the AKT pathway in melanoma cell lines. PLoS ONE 7, e42598.
  • Cullingford T. E., Butler M. J., Marshall A. K., el Tham L., Sugden P. H. and Clerk A. (2008) Differential regulation of Kruppel-like factor family transcription factor expression in neonatal rat cardiac myocytes: effects of endothelin-1, oxidative stress and cytokines. Biochim. Biophys. Acta 1783, 12291236.
  • Davies C. A., Loddick S. A., Toulmond S., Stroemer R. P., Hunt J. and Rothwell N. J. (1999) The progression and topographic distribution of interleukin-1beta expression after permanent middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow Metab. 19, 8798.
  • Feinberg M. W., Cao Z., Wara A. K., Lebedeva M. A., Senbanerjee S. and Jain M. K. (2005) Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. J. Biol. Chem. 280, 3824738258.
  • Ghoshal A., Das S., Ghosh S., Mishra M. K., Sharma V., Koli P., Sen E. and Basu A. (2007) Proinflammatory mediators released by activated microglia induces neuronal death in Japanese encephalitis. Glia 55, 483496.
  • Halle A., Hornung V., Petzold G. C., Stewart C. R., Monks B. G., Reinheckel T., Fitzgerald K. A., Latz E., Moore K. J. and Golenbock D. T. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9, 857865.
  • Katz J. P., Perreault N., Goldstein B. G., Lee C. S., Labosky P. A., Yang V. W. and Kaestner K. H. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129, 26192628.
  • Kaushik D. K., Gupta M., Das S. and Basu A. (2010) Kruppel-like factor 4, a novel transcription factor regulates microglial activation and subsequent neuroinflammation. J. Neuroinflammation 7, 68.
  • Kaushik D. K., Mukhopadhyay R., Kumawat K. L., Gupta M. and Basu A. (2012) Therapeutic targeting of Kruppel-like factor 4 abrogates microglial activation. J. Neuroinflammation 9, 57.
  • Kim Y. J., Hwang S. Y., Oh E. S., Oh S. and Han I. O. (2006) IL-1beta, an immediate early protein secreted by activated microglia, induces iNOS/NO in C6 astrocytoma cells through p38 MAPK and NF-kappaB pathways. J. Neurosci. Res. 84, 10371046.
  • Liao X., Sharma N., Kapadia F. et al. (2011) Kruppel-like factor 4 regulates macrophage polarization. J. Clin. Investig. 121, 27362749.
  • Liu J., Yang T., Liu Y., Zhang H., Wang K., Liu M., Chen G. and Xiao X. (2012) Kruppel-like factor 4 inhibits the expression of interleukin-1 beta in lipopolysaccharide-induced RAW264.7 macrophages. FEBS Lett. 586, 834840.
  • Luyendyk J. P., Schabbauer G. A., Tencati M., Holscher T., Pawlinski R. and Mackman N. (2008) Genetic analysis of the role of the PI3K-Akt pathway in lipopolysaccharide-induced cytokine and tissue factor gene expression in monocytes/macrophages. J. Immunol. 180, 42184226.
  • Mariathasan S. and Monack D. M. (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. 7, 3140.
  • McMahan C. J., Slack J. L., Mosley B. et al. (1991) A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 10, 28212832.
  • McNamee E. N., Ryan K. M., Kilroy D. and Connor T. J. (2010) Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity. Eur. J. Pharmacol. 626, 219228.
  • Meda L., Baron P., Prat E., Scarpini E., Scarlato G., Cassatella M. A. and Rossi F. (1999) Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J. Neuroimmunol. 93, 4552.
  • Obermeier F., Gross V., Scholmerich J. and Falk W. (1999) Interleukin-1 production by mouse macrophages is regulated in a feedback fashion by nitric oxide. J. Leukoc. Biol. 66, 829836.
  • Ogimoto K., Harris M. K., Jr and Wisse B. E. (2006) MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta. Endocrinology 147, 44454453.
  • Pathak S. K., Bhattacharyya A., Pathak S., Basak C., Mandal D., Kundu M. and Basu J. (2004) Toll-like receptor 2 and mitogen- and stress-activated kinase 1 are effectors of Mycobacterium avium-induced cyclooxygenase-2 expression in macrophages. J. Biol. Chem. 279, 5512755136.
  • Peng D. J., Zhou J. Y. and Wu G. S. (2010) Post-translational regulation of mitogen-activated protein kinase phosphatase-2 (MKP-2) by ERK. Cell cycle 9, 46504655.
  • Perrella M. A., Patterson C., Tan L., Yet S. F., Hsieh C. M., Yoshizumi M. and Lee M. E. (1996) Suppression of interleukin-1beta-induced nitric-oxide synthase promoter/enhancer activity by transforming growth factor-beta1 in vascular smooth muscle cells. Evidence for mechanisms other than NF-kappaB. J. Biol. Chem. 271, 1377613780.
  • Pinteaux E., Parker L. C., Rothwell N. J. and Luheshi G. N. (2002) Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83, 754763.
  • Ravichandran K., Tyagi A., Deep G., Agarwal C. and Agarwal R. (2011) Interleukin-1beta-induced iNOS expression in human lung carcinoma A549 cells: involvement of STAT and MAPK pathways. Indian J. Exp. Biol. 49, 840847.
  • Rothwell N. J. and Luheshi G. N. (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci. 23, 618625.
  • Ryu S. Y., Jeong K. S., Kang B. N., Park S. J., Yoon W. K., Kim S. H. and Kim T. H. (2000) Modulation of transferrin synthesis, transferrin receptor expression, iNOS expression and NO production in mouse macrophages by cytokines, either alone or in combination. Anticancer Res. 20, 33313338.
  • Saper C. B. and Breder C. D. (1992) Endogenous pyrogens in the CNS: role in the febrile response. Prog. Brain Res. 93, 419428. discussion 428-419.
  • Segre J. A., Bauer C. and Fuchs E. (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat. Genet. 22, 356360.
  • Sheng W., Zong Y., Mohammad A. et al. (2011) Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA(2)-IIA expression in astrocytes and microglia. J. Neuroinflammation 8, 121.
  • Toda Y., Tsukada J., Misago M., Kominato Y., Auron P. E. and Tanaka Y. (2002) Autocrine induction of the human pro-IL-1beta gene promoter by IL-1beta in monocytes. J. Immunol. 168, 19841991.
  • Tsujino M., Hirata Y., Imai T., Kanno K., Eguchi S., Ito H. and Marumo F. (1994) Induction of nitric oxide synthase gene by interleukin-1 beta in cultured rat cardiocytes. Circulation 90, 375383.
  • Turke A. B., Song Y., Costa C., Cook R., Arteaga C. L., Asara J. M. and Engelman J. A. (2012) MEK inhibition leads to PI3K/AKT activation by relieving a negative feedback on ERBB receptors. Cancer Res. 72, 32283237.
  • Wong H. R., Finder J. D., Wasserloos K., Lowenstein C. J., Geller D. A., Billiar T. R., Pitt B. R. and Davies P. (1996) Transcriptional regulation of iNOS by IL-1 beta in cultured rat pulmonary artery smooth muscle cells. Am. J. Physiol. 271, L166L171.